Why did APHIS decide to do this study? APHIS supports a One Health approach to address animal diseases, including SARS-CoV-2. White-tailed deer are susceptible to SARS-CoV-2, are abundant in the United States (approximately 30 million*), and often come into close contact with people. Given these factors, we felt it prudent to further investigate SARS-Cov-2 in wild deer. Studying the susceptibility of certain mammals, such as deer, to the SARS-CoV-2 virus helps to identify species that may serve as reservoirs or hosts for the virus. It also helps us understand the origin of the virus and predict its impacts on wildlife and the risks of cross-species transmission.
Posted by Gareth Icke - memes and headline comments by David Icke Posted on 7 October 2021
The U.S. Department of Agriculture’s (USDA) Animal and Plant Health Inspection Service (APHIS) recently completed a study that analyzed serum samples from free-ranging white-tailed deer for SARS-CoV-2 antibodies. Results of the study indicate that certain white-tailed deer populations in Illinois, Michigan, New York, and Pennsylvania were exposed to SARS-CoV-2.
Share This Article